Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2010
12/29/2010CN101926807A Fructose combination medicament
12/29/2010CN101926804A Ceforanide C-type crystal composition for injection and preparation method thereof
12/29/2010CN101926800A Pharmaceutical composition containing amrinone and preparation method and application thereof
12/29/2010CN101926799A Omeprazole sodium medicinal composition for injection and preparation method thereof
12/29/2010CN101926798A Dispersible tablet containing amlodipine and valsartan
12/29/2010CN101926792A Phospholipid complex containing silybin di-partial succinate, preparation method and application thereof
12/29/2010CN101926791A Phospholipid complex of silybin dihemisuccinate disodium and preparation method and application thereof
12/29/2010CN101926789A Improved topical medicaments and methods for photodynamic treatment of disease
12/29/2010CN101926786A Sustained release preparation for cantharidin and cantharidin extract
12/29/2010CN101926785A Medicinal controlled release preparation for treating parkinsonism and preparation method thereof
12/29/2010CN101926784A Electric hydrogel sticking agent for instantaneous pulse electric field transdermal drug administration and preparation method thereof
12/29/2010CN101926783A Drug slow control releaser and preparation method thereof
12/29/2010CN101926782A Oral solid drug compound containing dienogest
12/29/2010CN101926781A Solid medicinal composition of oxapium iodide
12/29/2010CN101926780A Freeze-dried preparation of stabilized anthracycline compound
12/29/2010CN101926779A Gemcitabine solid lipid nanospheres, preparation method thereof and use thereof
12/29/2010CN101926778A Pamidronate disodium freeze-dried powder injection and preparation method thereof
12/29/2010CN101926777A Method for preparing vidarabine monophosphate for injection
12/29/2010CN101926776A Salinomycin sodium suspension as well as preparation method and application thereof
12/29/2010CN101926775A Preparation and application methods of difunctional naonparticle preparation entrapping vincristine sulphate
12/29/2010CN101926774A Azithromycin powder composite and preparation method thereof
12/29/2010CN101926773A Medicament-carrying lipoid particulates and preparation method thereof
12/29/2010CN101926772A Polysaccharide nucleic acid fraction of bacillus calmette guerin lipid composition for livestock and freeze-dry preparation thereof
12/29/2010CN101926771A Acylated amylopectin-modified BCG-polysaccharide nucleic acid oral veterinary liposome and freeze-dried preparation thereof
12/29/2010CN101926770A Drug-loaded liposome and preparation method thereof
12/29/2010CN101926760A Dexamethasone injecta coated with 2-hydroxypropyl-beta-cyclodextrin
12/29/2010CN101926759A Idebenone injection containing 2-hydroxylpropyl-beta-cyclodextrin and preparation method thereof
12/29/2010CN101926758A Itraconazole suppository
12/29/2010CN101926757A Liquid composition of indissolvable medicines and preparation method thereof
12/29/2010CN101926756A Solid preparation of clopidogrel or pharmaceutically acceptable salt thereof
12/29/2010CN101926755A In-situ gel preparation of potassium dehydroandrographolide succinate and preparation method thereof
12/29/2010CN101703481B Ribavirin lipid microsphere effervescent granules
12/29/2010CN101623261B Cefamandole sodium proliposome preparation
12/29/2010CN101623255B Artesunate nanoemulsion drug composition and preparation method thereof
12/29/2010CN101584669B Melphalan freeze-dried powder injection
12/29/2010CN101564376B Decoquinate solid dispersoid and preparation method thereof
12/29/2010CN101559043B Benzene sulfonic acid levo-amlodipine pill and preparation method thereof
12/29/2010CN101524325B Compound menthol microemulsion and preparation for nose
12/29/2010CN101502486B Antineoplastic 2-methoxyestradiol injection containing cyclodextrin or cyclodextrin derivates
12/29/2010CN101439183B Method for preparing medicament adjuvant from starch
12/29/2010CN101433654B Chinese medicine preparation for treating women's chronic pelvic inflammatory disease and preparation method thereof
12/29/2010CN101422505B Foot-and-mouth disease vaccine and immunological stress resistance agent of other livestock and poultry and use thereof
12/29/2010CN101422426B Nitroimidazoles medicine nano montmorillonite sustained-release agent and preparation method thereof
12/29/2010CN101390825B Intra-ocular release system of voriconazole
12/29/2010CN101311188B Small molecule peptides inhibitor of human heparinase
12/29/2010CN101278934B Oral soft capsule compound preparations for curing cold
12/29/2010CN101214332B Composition for treating asthmatic bronchitis and bronchial asthma and preparation thereof
12/29/2010CN101209288B Corydalis decumbentis orally disintegrating tablets
12/29/2010CN101195032B Method for preparing coupled article of polyasparamide derivant and adriablastina, and uses thereof
12/29/2010CN101160354B Polymeric pharmaceutical agent for treatment of cancer and process for production of the same
12/29/2010CN101130063B Segmented intestine targeted preparation of orgotein polypeptide and method of preparing the same
12/29/2010CA2766908A1 Chewable drug
12/29/2010CA2766320A1 Acid-labile trigger units
12/29/2010CA2766272A1 Soricidin derived peptides and methods for the detection of trpv-6 cancers and drug delivery
12/29/2010CA2764423A1 Preparation comprising insulin, nicotinamide and an amino acid
12/29/2010CA2752865A1 Quickly soluble oral film dosage containing steviosides as a unpleasant taste masking agent
12/29/2010CA2698513A1 Micronized progesterone-based pharmaceutical composition and its uses
12/28/2010USRE42014 Pharmaceutical compositions
12/28/2010USRE42012 Compositions and methods for enhancing receptor-mediated cellular internalization
12/28/2010US7858749 Polymer-factor VIII moiety conjugates
12/28/2010US7858745 modified deoxycytidine kinase (dCK) mutants with enhanced activity towards nucleoside analogs used in cancer chemotherapy, and delivering the enzymes to specific target cells; specifically delivered to leukemic blast cells
12/28/2010US7858662 Medicament for the treatment of viral skin and tumour diseases
12/28/2010US7858656 Controlled release formulations containing an active ingredient, preferably melatonin and the method of preparation
12/28/2010US7858607 System for use by compounding pharmacists to produce hormone replacement medicine customized for each consumer
12/28/2010US7858597 formulations of ANGIOTENSIN II AT1 receptors antagonists, using the cyclodextrins or their derivatives, lipossomes and the biodegradable polymers; increasing the bio-availability of losartan
12/28/2010US7858589 A saponin possessing immune adjuvant activity, derived from Quillaja saponaria; an immunostimulatory oligonucleotide cotaining an unmethylated CpG dinucleotide,wherein the immunostimulatory oligonucleotide is not a part of a DNA vaccine vector
12/28/2010US7858588 Oligodeoxynucleic acid modified with (thio)phosphate
12/28/2010US7858576 Method for targeting lysosomal enzymes
12/28/2010US7858326 Immunoglobulin specific to eotaxin for use in diagnosis, prevention and treatment of infections, autoimmune, inflammatory and allergic disorders; chemotactic cytokines designated human eotaxins; selectively modulate leukocyte function
12/28/2010US7858322 Method of determining inhibition of binding to TRPM7 protein
12/28/2010US7858123 Inorganic materials for hemostatic modulation and therapeutic wound healing
12/28/2010US7858116 hepatocyte targeted composition comprising mixture of free recombinant human insulin isophane and free recombinant human regular insulin and mixture of recombinant human insulin isophane and recombinant human regular insulin associated with water insoluble target molecule complex; diabetes treatment
12/28/2010US7858115 Phospholipid gel compositions for drug delivery and methods of treating conditions using same
12/28/2010US7858108 Elutable surface coating
12/28/2010US7858082 providing a bulk of monomeric protein in a buffer solution and adding an excipient selected from bacteriostatic agents, surfactants, isotonicity agents, amino acids, antioxidants and combinations thereof; refereably the monomeric protein is IFN-beta
12/23/2010WO2010148288A2 Pharmaceutical formulations with low aqueous levels of free unbound drug
12/23/2010WO2010148253A2 Formulations for lysosomal enzymes
12/23/2010WO2010148223A2 Anti-vegf antibodies and their uses
12/23/2010WO2010148190A1 Aqueous pharmaceutical compositions containing borate-polyol complexes
12/23/2010WO2010148085A1 Rna nanoparticles and methods of use
12/23/2010WO2010148012A2 Hemostatic material and delivery device
12/23/2010WO2010148007A2 Nanoparticle and polymer formulations for thyroid hormone, analogs, antagonists, and formulations and uses thereof
12/23/2010WO2010147899A1 Stable nanoparticulate drug suspension
12/23/2010WO2010147831A1 Dendrimer based nanodevices for therapeutic and imaging purposes
12/23/2010WO2010147484A1 Compositions and methods for treatment of multiple sclerosis
12/23/2010WO2010147412A2 (metha)acrylate polymer, preparation method thereof and oil formulation containing the same
12/23/2010WO2010147302A2 Novel intermediates of voriconazole and preparation method of voriconazole using the same
12/23/2010WO2010147169A1 Pharmaceutical composition having improved solubility
12/23/2010WO2010147158A1 Gel enclosing a compound by means of low-molecular weight gelling agent
12/23/2010WO2010147144A1 Oral liquid preparation
12/23/2010WO2010146872A1 Composition for external application comprising aripiprazole and organic acid as active ingredients
12/23/2010WO2010146845A1 Soft capsule and manufacturing method therefor
12/23/2010WO2010146788A1 Apigenin-containing composition
12/23/2010WO2010146584A1 Novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer
12/23/2010WO2010146536A1 Suspension of particles with drug
12/23/2010WO2010146362A2 Materials and methods relating to glycosylation
12/23/2010WO2010144943A1 Buccal and/or sublingual therapeutic formulation
12/23/2010WO2010123946A3 Silk fibroin hydrogels and uses thereof
12/23/2010WO2010122385A8 Fast-acting insulin formulation
12/23/2010WO2010115830A3 Pharmaceutical agent
1 ... 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 ... 1712